Ventyx Biosciences, Inc.VTYXNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank67
3Y CAGR+1.0%
5Y CAGR+75.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+1.0%/yr
Annual compound
5Y CAGR
+75.3%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
16.6x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $116.72M | -21.4% |
| 2024 | $148.45M | -28.6% |
| 2023 | $207.99M | +83.8% |
| 2022 | $113.14M | +68.5% |
| 2021 | $67.15M | +852.4% |
| 2020 | $7.05M | +68.7% |
| 2019 | $4.18M | - |